|
IQVIA™ Real-World Insights Bibliography
| Long-term clinical and economic outcomes for patients with type 1 diabetes treated with insulin aspart versus human soluble insulin in Sweden |
| Author(s): Tucker D1, Brandt AS2, Foos V1, Munro V3, Goodall G1, Ray J1,Valentine WJ1, Roze S1, Palmer AJ1 |
| Affiliations(s): 1
1 CORE?Center for Outcomes Research, A Unit of IMS, Allschwil, Basel, Switzerland, 2 Novo Nordisk Scandinavia AB, Malmo, Sweden, 3 Novo Nordisk Ltd, Crawley, West Sussex, UK |
Publication(s):
Value in Health, Vol. 9, Issue 6, A226?A227
|
| Document Type(s): Poster, |
| Countries: Nordic, Sweden, |
C:
Y: |
Diabetes,
2006 |
|
L:
A: |
English
Economic evaluation, |
|
 |
| |
| |
 11 of 11
|
|
